Nektar Therapeutics | 贸易债权人



金融业
股票价格
USD
资产
USD 301.35M
现金及等价物
USD 41.03M
销售成本
USD 4.44M
流动资产
USD 281.36M
流动负债
USD 66.34M
债务
USD 0
股息收益率
0
EBIT
USD -34.35M
EBITDA
USD -31.81M
员工
137
EPS每股收益
USD -0.18
股本和储备
USD 85.09M
销售毛利
USD 13.75M
债务利息支出
USD 6.02M
利息收入
USD -0.18
贷款资金
USD 107.51M
市值
USD 12.55B
净收入
USD -37.06M
营业费用
USD 85.09M
营业利润
USD -34.35M
普通股股本
USD 19K
税前利润
USD -37.05M
销售收入
USD 24.12M
销售和管理费用
USD -0.18
股票
USD 14.46M
贸易债权人
USD 15.56M
应收帐款人
USD 0


贸易债权人 更改 日
Agios Pharmaceuticals USD 18.36M 1.2M 2025-12
ALKERMES USD 107.95M 39.95M 2025-12
Alterity Therapeutics Limited AUD 1.27M 1.81M 2024-12
Amgen USD 20.89B 1.25B 2025-12
Baxter International USD 999M 46M 2025-12
BioCryst Pharmaceuticals USD 5.57M 3.02M 2025-09
Biogen USD 432M 18.9M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Cara Therapeutics USD 2.42M 2.42M 2025-06
Cipla INR 30.35B 1.98B 2025-09
Dr.Reddys Laboratories INR 40.8B 548M 2025-12
Eisai JPY 85.49B 4.76B 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Esperion Therapeutics USD 77.51M 2.81M 2025-09
Exelixis USD 29.62M 4.27M 2025-12
Gilead Sciences USD 808M 226M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Grifols EUR 1.04B 183.31M 2025-06
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
Incyte USD 1.63B 1.46B 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Ironwood Pharmaceuticals USD 1.61M 224K 2025-09
Karyopharm Therapeutics USD 5.39M 2.8M 2025-09
MacroGenics USD 5.94M 1.28M 2025-09
Merck USD 4.15B 102M 2025-09
Nektar Therapeutics USD 15.56M 1.28M 2025-09
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Novartis USD 4.56B 49M 2025-09
Pfizer USD 5.02B 142M 2025-09
Roche Holding CHF 5.78B 1.27B 2025-12
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Takeda JPY 467.59B 28.61B 2025-12
Teva Pharmaceutical Industries USD 2.53B 176M 2025-12
Xencor USD 10.83M 1.75M 2025-12


Nektar Therapeutics 贸易债权人 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.